SAKINA ABOWATH: Open Payments
NPI 1326287525 · DIAMOND BAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 34 payments from 11 companies in 2025. Trend: 2023 $1,667 · 2024 $1,711 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $337 |
| Incyte Corporation | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| ABBVIE INC. | 3 | $87 |
| Amgen Inc. | 3 | $77 |
| LEO Pharma Inc. | 3 | $47 |
| PFIZER INC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Organon LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, Otezla, ADBRY, CIBINQO, COSENTYX, VTAMA.
Industry payments across CA — which companies pay providers there.
